Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

Antibiotics in infancy may impair insulin cell growth, increasing diabetes risk, while certain microbes could help promote ...

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice ...

In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...

Technosphere insulin was tied to improvements in HbA1c for adults with type 1 diabetes. Proper dosing at mealtimes is essential for maximizing glycemic benefits with technosphere insulin.

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

type 1 diabetes (T1D) is an autoimmune condition. The body’s immune system attacks the beta cells that make insulin in the pancreas, meaning that organ can’t produce that hormone naturally any ...